Actively hiring
Biotechnology
View 2 jobs
Claim pageClaim
Follow
Overview
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
Funding and backers
Team
201-500
employees, estimated range
Hiring now
2
+2 posted in 30 days
Momentum
27/100
hiring for its size
Last sign of life
this month
a posting or a news item
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

OriGene is a global leader in providing high-quality reagents to support genomic and proteomic research, including cDNA clones, antibodies…

Rhizome AI is a regulatory intelligence tool for life sciences. Cited answers from FDA, EMA and 15 other health authorities.

Developing Life-Changing Therapeutics For Our Pets Monoclonal antibodies (mAbs) for modern veterinary practices Developing Life-Changing…

AffiGEN supplies research-use antibodies, ELISA kits, recombinant proteins, PCR controls, assay kits, cloning reagents and molecular…

RQ Bio develops long-acting monoclonal antibodies for seasonal influenza, offering immediate, potent, and lasting protection against severe…

ArcaScience: AI-powered benefit-risk analysis platform for pharma. 24 proprietary models, 100B+ data points. Trusted for numerous…
Overview
Canton Biologics is a leading global CDMO focused on the development and GMP production of monoclonal antibodies, bispecific antibodies, fusion proteins and recombinant proteins, supporting IND submissions in compliance with FDA, EMA and NMPA standards.
Tech stack
Technologies named in job postings at Canton Biologics over the last 12 months, by layer, with the share of postings for each.
Technologies in use
1
Postings analysed
1
Stack modernity
90/100AI adopter
AI & ML
LLM
Sign in to see how your skills match this stack
Sign In
Growth
Hiring Momentum
28/100
Slowing
Open positions
2
0 opened / 0 closed in 30 days
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
AI/ML
50% ▲
DevOps
50% ▲






